Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s11605-015-2944-7.pdf
Reference21 articles.
1. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). radiation therapy oncology group. JAMA. 1999;281(17):1623-1627.
2. Perry KA, Enestvedt CK, Diggs BS, Jobe BA, Hunter JG. Perioperative outcomes of laparoscopic transhiatal inversion esophagectomy compare favorably with those of combined thoracoscopic-laparoscopic esophagectomy. Surg Endosc. 2009;23(9):2147-2154.
3. Holscher AH, Drebber U, Schmidt H, Bollschweiler E. Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma. Ann Surg. 2014;260(5):779-84; discussion 784-5.
4. Meredith KL, Weber JM, Turaga KK, et al. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol. 2010;17(4):1159-1167.
5. Slotta-Huspenina J, Wolff C, Drecoll E, et al. A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br J Cancer. 2013;109(2):370-378.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and validation of a molecular tool to predict pathologic complete response in esophageal adenocarcinoma;Diseases of the Esophagus;2022-06-25
2. Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma;Cancers;2022-02-16
3. A single-nucleotide-polymorphism in the 5′-flanking region ofMSX1gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma;Therapeutic Advances in Medical Oncology;2022-01
4. The role of transforming growth factor β in upper gastrointestinal cancers: A systematic review;Cancer Treatment Reviews;2021-11
5. Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study;Journal of Thoracic Disease;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3